Targeted regimens focus on critical signaling molecules and cascades driving RCC proliferation [13], such as the VEGF pathway which promotes tumor angiogenesis [15,16] and the mTOR pathway which governs pivotal cellular functions [17,18]. The gene discussed is VEGFA; the disease is neoplasm.